Company / Current Liabilities per Share
United Therapeutics Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$12.50
FY2025
5-year range
$6.86 / $17.47
FY2021-FY2025
Trend
-20.3%
vs FY2024
Sector context
#15 of 210
Health Care
What the data says
Among 210 Health Care companies, United Therapeutics is in the bottom 7% for current liabilities per share. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $6.40 in FY2018 to $17.47 in FY2023.
Based on SEC 10-K filings.
12.50 in FY2025 with a 5-year CAGR of +11.2%. Top quartile in the Health Care sector.
Improved from $17.47 to $12.50 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +18.0%
- 5-Year CAGR
- +11.2%
- 10-Year CAGR
- -
Sector benchmark
-47.4% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 20.3% year-over-year.
- Ranks #15 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2023.
- Lowest current liabilities per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.50 | -20.3% |
| FY2024 | $15.69 | -10.2% |
| FY2023 | $17.47 | +129.7% |
| FY2022 | $7.61 | +10.9% |
| FY2021 | $6.86 | -6.9% |
| FY2020 | $7.37 | -30.6% |
| FY2019 | $10.62 | +66.1% |
| FY2018 | $6.40 | -38.2% |
| FY2017 | $10.35 | +42.4% |
| FY2016 | $7.27 | -22.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026